Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07491523
Double Immunosuppression With or Without Anti-fibrotic in Scleroderma ILD
Sponsor: University of Patras
View on ClinicalTrials.gov
Summary
Patients with ssc-ild receiving double immunosuppression with or without anti fibrotic tratment
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
35
Start Date
2025-06-01
Completion Date
2027-03
Last Updated
2026-03-24
Healthy Volunteers
No
Conditions
Interventions
DRUG
Antifibrotic drugs (nidanib or pirfenidone)
Ssc - ild
DRUG
MMF Immunosuppression
we will compare patients with SSc-ILD taking RTX and mmf and patients that are taking RTX,mmf and nintedanib
Locations (1)
University of patras
Pátrai, Greece